Macaluso FS, Fries W, Viola A, Centritto A, et al. The SPOSIB SB2 Sicilian Cohort: Safety and Effectiveness of Infliximab Biosimilar SB2 in Inflammatory Bowel Diseases, Including Multiple Switches. Inflamm Bowel Dis 2021;27:182-189.
PMID: 32083291